Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Laboratoires Servier

Tracked across 6 events · 45 articles · First seen Apr 10, 2026 · Last active Sep 10, 2026

Sentiment
31
Attention
4
Events
6
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 70
Business
Impact: Laboratoires Servier is acquiring the muscular dystrophy business of Edgewise Therapeutics, which will enhance its position in neuromuscular disorders and support its 2030 ambition in neurology.
Jun 01, 2026 · 6 articles
4 70
Business
Impact: Laboratoires Servier is strengthening its commitment to rare neurological diseases and advancing its 2030 ambition by partnering with Foundation to develop innovative treatments.
Jun 10, 2026 · 9 articles
2 40
Business
Impact: Collaboration partner; contributes to Insilico's revenue growth, but no direct impact from index inclusion.
Jul 20, 2026 · 6 articles
3 0
Business
Impact: Commercial product OJEMDA included in acquired portfolio.
Jul 14, 2026 · 6 articles
4 5
Tech
Insilico Medicine announced on September 9-10, 2026 that it has dosed the first patient with Rentosertib (ISM001-055 / INS018_055) in GENESIS-IPF-3, a Phase III clinical trial for idiopathic pulmonary fibrosis (IPF), at United Medical College…
Impact: Laboratoires Servier is listed as a collaboration partner of Insilico Medicine, supporting its commercial model. The event has minimal direct impact on Laboratoires Servier.
Sep 10, 2026 · 6 articles
4 0
Business
Impact: Laboratoires Servier is mentioned as part of Royalty Pharma's portfolio but is unaffected by this event.
Sep 04, 2026 · 12 articles
ERGEN INTELLIGENCE
Track Laboratoires Servier live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.